| 000 | 01521 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511181233.0 | ||
| 264 | 0 | _c19920826 | |
| 008 | 199208s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00092a024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHrib, N J | |
| 245 | 0 | 0 |
_a3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJul 1992 |
||
| 300 |
_a2712-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a8-Hydroxy-2-(di-n-propylamino)tetralin |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xmetabolism |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aThiazoles _xmetabolism |
| 650 | 0 | 4 | _aThiazolidines |
| 700 | 1 | _aJurcak, J G | |
| 700 | 1 | _aBregna, D E | |
| 700 | 1 | _aDunn, R W | |
| 700 | 1 | _aGeyer, H M | |
| 700 | 1 | _aHartman, H B | |
| 700 | 1 | _aRoehr, J E | |
| 700 | 1 | _aRogers, K L | |
| 700 | 1 | _aRush, D K | |
| 700 | 1 | _aSzczepanik, A M | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 35 _gno. 14 _gp. 2712-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00092a024 _zAvailable from publisher's website |
| 999 |
_c1359616 _d1359616 |
||